| Financial Year |
March 31 2023 |
| Monetary Funds |
13,112,205,466.88 |
| Held-for-trading Financial Assets |
528,456,648.37 |
| Notes Receivable |
260,000,000.00 |
| Accounts Receivable |
709,882,984.85 |
| Advances to Suppliers |
53,243,383.76 |
| Other Receivables |
131,880,448.51 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
10,812,980,729.35 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
729,000,494.59 |
| Total Current Assets |
26,337,650,156.31 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
187,680,622.80 |
| Fixed Assetes |
330,896,840.65 |
| Under-construction Projects |
74,858,642.95 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
55,160,649.85 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
57,314,275.93 |
| Deferred Income Tax Assets |
120,537,370.19 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,249,524,418.74 |
| Total Assets |
27,587,174,575.05 |
| Short-Term Loans |
8,031,754,101.32 |
| Trading Financial liabilities |
2,272,780,341.23 |
| Notes Payable |
-- |
| Accounts Payable |
396,602,532.75 |
| Accounts Received In Advance |
2,215,477.13 |
| Employee Compensation Payable |
180,091,275.16 |
| Taxes Payable |
395,064,217.85 |
| Interest Payable |
-- |
| Dividend Payable |
329,184,100.44 |
| Other payables |
716,836,658.09 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
841,917,289.00 |
| Other Current Liabilities |
281,209,790.07 |
| Sub-Total of Current Liabilities |
13,312,206,815.02 |
| Long-term Loans |
1,330,961,111.11 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
22,323,365.91 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,671,927,213.30 |
| Total Liabilities |
14,984,134,028.32 |
| Paid-In Capital(Or Share Stock) |
523,117,764.00 |
| Capital Surplus |
467,409,857.37 |
| Surplus Reserve |
335,262,880.82 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
9,517,434,754.53 |
| Minority Stockholder's Interest |
1,758,694,637.05 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,844,345,909.68 |
| Owner's Equity（Stockholder's Equity） |
12,603,040,546.73 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
27,587,174,575.05 |
